https://agerafenibinhibitor.co....m/?p=5638preview=tru
The efficacy of the anticancer drug 5-FU is lessened by a complex interplay of severe side effects and the lowered responsiveness of the body to prolonged chemotherapy. A defining characteristic of cancer cells is elevated levels of endogenous copper (Cu). This study focused on the effect of 5-FU, co-administered with copper and disulfiram, on diethyl nitrosamine-phenobarbital-induced hepatocellular carcinoma (HCC) in rats. Rats induced with HCC, after treatment with the test chemicals, had their blood and liver samples rigorousl